Investor revolt at Bayer to escalate after CEO keeps his job

Lower market value: Bayer logo sits on the exterior of the company’s pharmaceutical factory in Berlin. Bayer has lost 35 billion euros (US$39bil) in market value, due in large part to subsequent lawsuits that allege the main ingredient of Roundup – the weedkiller Bayer acquired through Monsanto – causes cancer. — Bloomberg

FRANKFURT: The shareholder rebellion at Bayer AG is poised to worsen after its supervisory board ignored an unprecedented no-confidence vote against the leadership of chief executive officer Werner Baumann.

Several top investors of the German chemicals and drugs giant are frustrated with directors’ decision to back Baumann and his strategy that led to the US$63bil takeover of Monsanto, according to people familiar with the matter.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Bayer , investor , revolt , CEO , job ,


Next In Business News

Bursa Carbon Exchange inks MoU, MOC to grow voluntary carbon market in Malaysia
Maybank supports distribution of RM100 eMADANI credit
Ringgit closes higher against greenback on expectation us rate hike cycle is over
SCIB gets RM16.8mil contract
Citaglobal, Masdar, and TNB Renewables team up for a US$2bil solar farm project in Pahang
UMW Holdings disposes of land to Perodua
Eita's subsidiary bags RM56.31mil TNB contract
Bioalpha to develop an 8-acre agro park in Langkawi
KJTS Group inks IPO underwriting agreement
FBM KLCI declines amid mixed regional trading

Others Also Read